NASDAQ: YI111 Inc Stock
$2.73+0.09 (+3.41%)
Updated Jun 8, 2023
YI Price
$2.73
Fair Value Price
$11.38
Market Cap
$228.00M
52 Week Low
$1.76
52 Week High
$4.00
P/E
-3.77x
P/B
-3.79x
P/S
0.13x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.96B
Earnings
-$59.81M
Gross Margin
6.2%
Operating Margin
-2.98%
Profit Margin
-3.1%
Debt to Equity
-6.82
Operating Cash Flow
-$3M
Beta
0.8
Next Earnings
Jun 15, 2023
Ex-Dividend
N/A
Next Dividend
N/A
YI Overview
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
Zen Score
–
Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how YI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
YI ($2.73) is undervalued by 76% relative to our estimate of its Fair Value price of $11.38 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
YI ($2.73) is significantly undervalued by 76% relative to our estimate of its Fair Value price of $11.38 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
YI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more YI due diligence checks available for Premium users.
Be the first to know about important YI news, forecast changes, insider trades & much more!
YI News
Valuation
YI fair value
Fair Value of YI stock based on Discounted Cash Flow (DCF)
Price
$2.73
Fair Value
$11.38
Undervalued by
76.00%
YI ($2.73) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
YI ($2.73) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
YI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
YI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-3.77x
Industry
8.8x
Market
52.58x
YI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-3.79x
Industry
1.36x
YI's financial health
Profit margin
Revenue
$595.2M
Net Income
-$16.4M
Profit Margin
-2.8%
YI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
YI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$498.4M
Liabilities
$405.4M
Debt to equity
-6.82
YI's short-term assets ($468.96M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
YI's short-term assets ($468.96M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
YI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
YI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
YI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
YI vs Pharmaceutical Retailer Stocks
111 Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.